Literature DB >> 1981318

Withdrawal phenomena after atenolol and bopindolol: haemodynamic responses in healthy volunteers.

R J Walden1, B Tomlinson, B Graham, J B Liu, B N Prichard.   

Abstract

1. The effect of withdrawal of atenolol and bopindolol administration was studied in 12 normal volunteers; six on each drug. 2. Following sub-maximal cycle-ergometer exercise training six sets of base-line observations were made of heart-rate (HR) and blood pressure (BP) responses; supine, 60 degrees head-up tilt, during graduated isoprenaline infusion and sub-maximal cycle exercise. 3. The results show that withdrawal phenomena occur following both drug treatments. Atenolol produced a hypersensitivity to isoprenaline and a small overshoot of HR in response to physiological manoeuvres. In contrast bopindolol produced a prolonged state of reduced sensitivity to isoprenaline and some evidence of overshoot of HR with physiological manoeuvres. The differences between the responses may be explained by the different properties of the two beta-adrenoceptor blocking drugs. 4. Some subjects showed clear evidence of overshoot of HR and BP on exercise demonstrating that certain individuals may be more prone to have withdrawal effects than others. 5. The length of time during which withdrawal phenomena can occur is probably longer than has previously been realised. 6. Hormonal changes were found in the withdrawal period (Walden et al., 1990).

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1981318      PMCID: PMC1368245          DOI: 10.1111/j.1365-2125.1990.tb03813.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  12 in total

1.  Abrupt withdrawal of beta-blocking agents in patients with arterial hypertension. Effect on blood pressure, heart rate and plasma catecholamines and prolactin.

Authors:  O Lederballe Pedersen; E Mikkelsen; J Lanng Nielsen; N J Christensen
Journal:  Eur J Clin Pharmacol       Date:  1979-04-17       Impact factor: 2.953

2.  The effect of intrinsic sympathomimetic activity on beta-receptor responsiveness after beta-adrenoceptor blockade withdrawal.

Authors:  R J Walden; P Bhattacharjee; B Tomlinson; J Cashin; B R Graham; B N Prichard
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

3.  Adrenergic hypersensitivity after beta-blocker withdrawal.

Authors:  P J Ross; M J Lewis; D J Sheridan; A H Henderson
Journal:  Br Heart J       Date:  1981-06

4.  Abrupt withdrawal of pindolol or metoprolol after chronic therapy.

Authors:  E Szécsi; S Kohlschütter; W Schiess; E Lang
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

5.  Shortened platelet survival time and enhanced heart rate responses after abrupt withdrawal of propranolol from normal subjects.

Authors:  R E Goldstein; L C Corash; J F Tallman; C R Lake; J Hyde; C C Smith; N L Capurro; J C Anderson
Journal:  Am J Cardiol       Date:  1981-05       Impact factor: 2.778

Review 6.  Angiotensin converting enzyme inhibition and the kidney.

Authors:  N K Hollenberg
Journal:  Curr Opin Cardiol       Date:  1988       Impact factor: 2.161

7.  Adrenergic responsiveness after abrupt propranolol withdrawal in normal subjects and in patients with angina pectoris.

Authors:  J Lindenfeld; M H Crawford; R A O'Rourke; S P Levine; M M Montiel; L D Horwitz
Journal:  Circulation       Date:  1980-10       Impact factor: 29.690

8.  Mechanism of propranolol withdrawal phenomena.

Authors:  S Nattel; R E Rangno; G Van Loon
Journal:  Circulation       Date:  1979-06       Impact factor: 29.690

9.  Cardiac hyper- and hyporesponsiveness after pindolol withdrawal.

Authors:  R E Rangno; S Langlois; J Stewart
Journal:  Clin Pharmacol Ther       Date:  1982-05       Impact factor: 6.875

10.  Rebound phenomena following gradual withdrawal of chronic metoprolol treatment in patients with ischemic heart disease.

Authors:  G Olsson; P Hjemdahl; N Rehnqvist
Journal:  Am Heart J       Date:  1984-09       Impact factor: 4.749

View more
  4 in total

Review 1.  Bopindolol. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy.

Authors:  D W Harron; K L Goa; H D Langtry
Journal:  Drugs       Date:  1991-01       Impact factor: 9.546

2.  Withdrawal phenomena after atenolol and bopindolol: hormonal changes in normal volunteers.

Authors:  R J Walden; B Tomlinson; B Graham; C Smith; D J Betteridge; B N Prichard
Journal:  Br J Clin Pharmacol       Date:  1990-10       Impact factor: 4.335

Review 3.  Adverse reactions with beta-adrenoceptor blocking drugs. An update.

Authors:  R V Lewis; C Lofthouse
Journal:  Drug Saf       Date:  1993-10       Impact factor: 5.606

Review 4.  Which ancillary properties of beta-adrenoceptor blocking drugs influence their therapeutic or adverse effects?: a review.

Authors:  P Turner
Journal:  J R Soc Med       Date:  1991-11       Impact factor: 18.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.